These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 2784162

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of 3'-azido-2',3'-dideoxythymidine (AZT) and neutralizing antibody on human immunodeficiency virus (HIV)-induced cytopathic effects: implication of giant cell formation for the spread of virus in vivo.
    Nakashima H, Tochikura T, Kobayashi N, Matsuda A, Ueda T, Yamamoto N.
    Virology; 1987 Jul; 159(1):169-73. PubMed ID: 3111083
    [Abstract] [Full Text] [Related]

  • 5. Neutralizing antibodies in relation to antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus type I.
    Böttiger B, Ljunggren K, Karlsson A, Krohn K, Fenyö EM, Jondal M, Biberfeld G.
    Clin Exp Immunol; 1988 Sep; 73(3):339-42. PubMed ID: 3208445
    [Abstract] [Full Text] [Related]

  • 6. Further isolation of HIV strains in Palermo: some biological properties of the new isolates.
    Lupo G, Spadaro F, Portera M, Torregrossa MV, Russo Alesi D, Vitale F, Romano N.
    Microbiologica; 1988 Oct; 11(4):329-37. PubMed ID: 3063924
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers.
    Ljunggren K, Moschese V, Broliden PA, Giaquinto C, Quinti I, Fenyö EM, Wahren B, Rossi P, Jondal M.
    J Infect Dis; 1990 Feb; 161(2):198-202. PubMed ID: 2299204
    [Abstract] [Full Text] [Related]

  • 12. A sensitive assay for detection and measurement of neutralising antibody to human immunodeficiency virus.
    Osborne R, Mason H, Browning M, Mitchell R, Jarrett W.
    J Virol Methods; 1992 Sep; 39(1-2):15-26. PubMed ID: 1430060
    [Abstract] [Full Text] [Related]

  • 13. Neutralizing antibodies and the course of HIV-induced disease.
    Wendler I, Bienzle U, Hunsmann G.
    AIDS Res Hum Retroviruses; 1987 Sep; 3(2):157-63. PubMed ID: 3650100
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Functional antibody response to human cytomegalovirus in immunocompetent and HIV-1 infected individuals with antibodies that inhibit virus penetration into cells and intercellular transmission of viral infection.
    Alberola J, Tamarit A, Navarro D.
    J Med Microbiol; 1999 Oct; 48(10):947-954. PubMed ID: 10510972
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas.
    Carrow EW, Vujcic LK, Glass WL, Seamon KB, Rastogi SC, Hendry RM, Boulos R, Nzila N, Quinnan GV.
    AIDS Res Hum Retroviruses; 1991 Oct; 7(10):831-8. PubMed ID: 1720630
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Neutralizing antibodies and serum interferon levels in the different stages of HIV infection.
    Szabó B, Tóth FD, Kiss J, Ujhelyi E, Füst G, Horváth A, Hollán SR.
    Acta Virol; 1990 Apr; 34(2):164-70. PubMed ID: 1975977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.